2023 Fall Clinical Virtual Grand Rounds
2023 Virtual Grand Rounds Session 13: September 27, 2023 - Challenging Cases in Dermatology
Fall Clinical Virtual Grand Rounds consist of regularly scheduled CME sessions on a variety of dermatological diseases, delivered by the top experts in dermatology. Please join us for this week's session:
Wednesday, September 27, 2023
8 PM ET / 5 PM PT
Challenging Cases in Dermatology
In order to ensure educational material is relevant, educational materials will expire after a certain time period. This course will be available for the following dates:
September 28, 2023
September 28, 2024
At the completion of this activity, participants should be better able to:
Recognize that IL-4 and IL-13 are signature cytokines of type 2 inflammatory response
Understand that Type 2 inflammatory response involves mast cells, eosinophils, and basophils
Recognize the common signs and symptoms of Staph Scalded Skin Syndrome
Understand treatment of Staph Scalded Skin Syndrome
Recognize the rare benign vascular disorder of Achenbach Syndrome
Understand the differential diagnosis and workup of Achenbach Syndrome
David Cleaver, DO
Northeast Regional Medical Center, STILL OPTI Dermatology Residency
Jonathan Crane, DO
Sampson Regional Medical Center
Alexandra Golant, MD
Medical Director, Dermatology Faculty Practice
Associate Director, Residency Program
Department of Dermatology
Icahn School of Medicine at Mount Sinai
New York, NY
Jere Mammino, DO
Orlando Dermatology Residency Program
Advanced Dermatology & Cosmetic Surgery
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Institute for Continuing Healthcare Education and CMEsquared. The Institute is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The Institute for Continuing Healthcare Education designates this live and enduring activity for a maximum of 1 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: Abbvie, Castle, Meditech, Regeneron
Speaker's Bureau: Abbvie, Bristol-Meyers Squibb, Pfizer
Dr. Krane has disclosed that they have no relevant financial relationships with any Ineligible Company in the past 24 months.
Consultant: Regeneron, Sanofi, Lilly, Incyte, Dermavant, Arcutis, LEO Pharma, Janssen
Speakers’ Bureau or Honoraria: Regeneron, Sanofi, Lilly, Incyte, Dermavant, Arcutis
Dr. Mammino has disclosed that they have no relevant financial relationships with Ineligible Companies in the past 24 months.
The Institute discloses that all relevant conflicts have been satisfactorily mitigated.